ADAM10 and neoplasm: In HR patients, the relative risk for tumor relapse is/was similar as for T patients, and in fact, some of the pEV characteristics were similar in both group, as, for example, the up-regulation of microRNAs not found in healthy controls (Fig 2B and D) and their content of active ADAM10 (Fig 2E).